[New post] Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer
Daniel Webster posted: " HOUSTON--(BUSINESS WIRE)--ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that Dr. Revati Shreeniwas has joined the company as Chi" New post on dWeb.News Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer by Daniel Webster HOUSTON--(BUSINESS WIRE)--ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today annou...